Jared J. Fradette

1.8k total citations
22 papers, 669 citations indexed

About

Jared J. Fradette is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Jared J. Fradette has authored 22 papers receiving a total of 669 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 9 papers in Immunology and 7 papers in Molecular Biology. Recurrent topics in Jared J. Fradette's work include Cancer Immunotherapy and Biomarkers (6 papers), Immune Cell Function and Interaction (5 papers) and Cancer Cells and Metastasis (5 papers). Jared J. Fradette is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Immune Cell Function and Interaction (5 papers) and Cancer Cells and Metastasis (5 papers). Jared J. Fradette collaborates with scholars based in United States, Netherlands and Canada. Jared J. Fradette's co-authors include Don L. Gibbons, Jessica Konen, Samrat T. Kundu, Chad J. Creighton, Kenneth L. Scott, B. Leticia Rodriguez, Caitlin L. Grzeskowiak, Lixia Diao, David H. Peng and Leticia Rodríguez and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Genes & Development.

In The Last Decade

Jared J. Fradette

21 papers receiving 665 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jared J. Fradette United States 16 319 272 171 132 107 22 669
Alexia Conte Italy 7 307 1.0× 226 0.8× 125 0.7× 61 0.5× 166 1.6× 8 614
Aude Mallavialle France 15 409 1.3× 337 1.2× 184 1.1× 161 1.2× 104 1.0× 23 791
Julia Mitschke Germany 6 545 1.7× 464 1.7× 102 0.6× 351 2.7× 93 0.9× 7 890
Chongkui Sun China 13 337 1.1× 192 0.7× 125 0.7× 124 0.9× 31 0.3× 16 621
Erik H. Knelson United States 15 397 1.2× 214 0.8× 183 1.1× 109 0.8× 166 1.6× 22 703
Gaia Barisione Italy 12 268 0.8× 294 1.1× 452 2.6× 97 0.7× 57 0.5× 16 808
Aleksandra Markiewicz Poland 15 287 0.9× 499 1.8× 90 0.5× 283 2.1× 29 0.3× 33 714
Laura Gómez-Cuadrado United Kingdom 9 347 1.1× 392 1.4× 159 0.9× 152 1.2× 100 0.9× 9 745
Miwako Kakiuchi Japan 8 443 1.4× 413 1.5× 392 2.3× 185 1.4× 54 0.5× 14 1.1k
Abhishek S. Kashyap Switzerland 9 186 0.6× 225 0.8× 123 0.7× 80 0.6× 46 0.4× 14 489

Countries citing papers authored by Jared J. Fradette

Since Specialization
Citations

This map shows the geographic impact of Jared J. Fradette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jared J. Fradette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jared J. Fradette more than expected).

Fields of papers citing papers by Jared J. Fradette

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jared J. Fradette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jared J. Fradette. The network helps show where Jared J. Fradette may publish in the future.

Co-authorship network of co-authors of Jared J. Fradette

This figure shows the co-authorship network connecting the top 25 collaborators of Jared J. Fradette. A scholar is included among the top collaborators of Jared J. Fradette based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jared J. Fradette. Jared J. Fradette is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Konen, Jessica, B. Leticia Rodriguez, Jared J. Fradette, et al.. (2023). Autotaxin suppresses cytotoxic T cells via LPAR5 to promote anti–PD-1 resistance in non–small cell lung cancer. Journal of Clinical Investigation. 133(17). 18 indexed citations
2.
Rodriguez, B. Leticia, Limo Chen, Yanli Li, et al.. (2023). Targeting immunosuppressive Ly6C+ classical monocytes reverses anti-PD-1/CTLA-4 immunotherapy resistance. Frontiers in Immunology. 14. 1161869–1161869. 5 indexed citations
3.
Tian, Yanhua, et al.. (2023). ZEB1 Is Regulated by K811 Acetylation to Promote Stability, NuRD Complex Interactions, EMT, and NSCLC Metastasis. Molecular Cancer Research. 21(8). 779–794. 5 indexed citations
4.
Konen, Jessica, et al.. (2023). 571 Exploring anti-PD-1 resistance mechanisms for therapeutic targeting in non-small cell lung cancer. SHILAP Revista de lepidopterología. A648–A648. 1 indexed citations
5.
Fradette, Jared J., et al.. (2022). Dance of The Golgi: Understanding Golgi Dynamics in Cancer Metastasis. Cells. 11(9). 1484–1484. 40 indexed citations
6.
Kundu, Samrat T., B. Leticia Rodriguez, Jared J. Fradette, et al.. (2022). The microRNA-183/96/182 cluster inhibits lung cancer progression and metastasis by inducing an interleukin-2-mediated antitumor CD8+ cytotoxic T-cell response. Genes & Development. 36(9-10). 582–600. 14 indexed citations
7.
Konen, Jessica, B. Leticia Rodriguez, Joshua K. Ochieng, et al.. (2021). Dual Inhibition of MEK and AXL Targets Tumor Cell Heterogeneity and Prevents Resistant Outgrowth Mediated by the Epithelial-to-Mesenchymal Transition in NSCLC. Cancer Research. 81(5). 1398–1412. 24 indexed citations
8.
Peng, David H., B. Leticia Rodriguez, Lixia Diao, et al.. (2021). Th17 cells contribute to combination MEK inhibitor and anti-PD-L1 therapy resistance in KRAS/p53 mutant lung cancers. Nature Communications. 12(1). 2606–2606. 53 indexed citations
9.
Konen, Jessica, B. Leticia Rodriguez, Jared J. Fradette, et al.. (2021). Targeting CDK4 overcomes EMT-mediated tumor heterogeneity and therapeutic resistance in KRAS-mutant lung cancer. JCI Insight. 6(17). 14 indexed citations
10.
Cascone, Tina, Jared J. Fradette, Monika Pradhan, & Don L. Gibbons. (2021). Tumor Immunology and Immunotherapy of Non-Small-Cell Lung Cancer. Cold Spring Harbor Perspectives in Medicine. 12(5). a037895–a037895. 43 indexed citations
11.
Hirz, Taghreed, Irene Guijarro, Monique B. Nilsson, et al.. (2020). Targeting of CD40 and PD-L1 Pathways Inhibits Progression of Oral Premalignant Lesions in a Carcinogen-induced Model of Oral Squamous Cell Carcinoma. Cancer Prevention Research. 14(3). 313–324. 25 indexed citations
12.
Kundu, Samrat T., Caitlin L. Grzeskowiak, Jared J. Fradette, et al.. (2020). IMPAD1 and KDELR2 drive invasion and metastasis by enhancing Golgi-mediated secretion. Oncogene. 39(37). 5979–5994. 31 indexed citations
13.
Ochieng, Joshua K., et al.. (2020). MBIP (MAP3K12 binding inhibitory protein) drives NSCLC metastasis by JNK-dependent activation of MMPs. Oncogene. 39(43). 6719–6732. 15 indexed citations
14.
Yamauchi, Mitsuo, Don L. Gibbons, Chenghang Zong, et al.. (2020). Fibroblast heterogeneity and its impact on extracellular matrix and immune landscape remodeling in cancer. Matrix Biology. 91-92. 8–18. 49 indexed citations
15.
Coyaud, Étienne, Samrat T. Kundu, David H. Peng, et al.. (2019). ZEB1/NuRD complex suppresses TBC1D2b to stimulate E-cadherin internalization and promote metastasis in lung cancer. Nature Communications. 10(1). 5125–5125. 73 indexed citations
16.
Ungewiss, Christin, Jared J. Fradette, B. Leticia Rodriguez, et al.. (2019). A novel ex vivo tumor system identifies Src-mediated invasion and metastasis in mesenchymal tumor cells in non-small cell lung cancer. Scientific Reports. 9(1). 4819–4819. 20 indexed citations
17.
Konen, Jessica, B. Leticia Rodriguez, Jared J. Fradette, et al.. (2019). Ntrk1 Promotes Resistance to PD-1 Checkpoint Blockade in Mesenchymal Kras/p53 Mutant Lung Cancer. Cancers. 11(4). 462–462. 24 indexed citations
18.
Kundu, Samrat T., Caitlin L. Grzeskowiak, Jared J. Fradette, et al.. (2018). TMEM106B drives lung cancer metastasis by inducing TFEB-dependent lysosome synthesis and secretion of cathepsins. Nature Communications. 9(1). 2731–2731. 101 indexed citations
19.
Chen, Limo, Lixia Diao, Yongbin Yang, et al.. (2017). Abstract 567: CD38 blockade overcomes the immune resistance to anti-PD-L1 therapy by boosting CD8 T cell response. Cancer Research. 77(13_Supplement). 567–567.
20.
Chen, Limo, Xiaohui Yi, Sangeeta Goswami, et al.. (2016). Growth and metastasis of lung adenocarcinoma is potentiated by BMP4-mediated immunosuppression. OncoImmunology. 5(11). e1234570–e1234570. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexia Conte Breakdown of academic impact, for papers by Aude Mallavialle Breakdown of academic impact, for papers by Julia Mitschke Breakdown of academic impact, for papers by Chongkui Sun Breakdown of academic impact, for papers by Erik H. Knelson Breakdown of academic impact, for papers by Gaia Barisione Breakdown of academic impact, for papers by Aleksandra Markiewicz Breakdown of academic impact, for papers by Laura Gómez-Cuadrado Breakdown of academic impact, for papers by Miwako Kakiuchi Breakdown of academic impact, for papers by Abhishek S. Kashyap
Rankless by CCL
2026